MEDISYNALL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDISYNALL
Largest movements
- Receivables within one year -€89,130
down €89,130 (-99.3%), from €89,734 to €605
of which Trade receivables: -€88,722
- Other debts -€74,074
down €74,074 (-13.1%), from €564,479 to €490,405
- Profit (loss) carried forward -€23,418
down €23,418 (-13.5%), from -€172,901 to -€196,319
- Staff costs -€60,301
no longer reported in 2025 (was €60,301)
- Gross operating margin -€23,355
down €23,355, from €21,321 to -€2,034
- Other operating charges +€3,090
up €3,090 (+88.6%), from €3,490 to €6,580
- Financial charges -€1,974
down €1,974 (-66.4%), from €2,972 to €998
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,490,819 | €1,391,559 | -€99,261 | -6.7% |
| Fixed assets | 21/28 | €1,400,918 | €1,387,051 | -€13,867 | -1.0% |
| Tangible fixed assets | 22/27 | €400,918 | €387,051 | -€13,867 | -3.5% |
| Land and buildings | 22 | €400,918 | €387,051 | -€13,867 | -3.5% |
| Financial fixed assets | 28 | €1,000,000 | €1,000,000 | = | 0.0% |
| Current assets | 29/58 | €89,902 | €4,508 | -€85,394 | -95.0% |
| Amounts receivable within one year | 40/41 | €89,734 | €605 | -€89,130 | -99.3% |
| Trade receivables | 40 | €88,722 | - | -€88,722 | |
| Other amounts receivable | 41 | €1,012 | €605 | -€408 | -40.3% |
| Cash at bank and in hand | 54/58 | €167 | €3,903 | +€3,736 | +2,232% |
| Total equity and liabilities | 10/49 | €1,490,819 | €1,391,559 | -€99,261 | -6.7% |
| Equity | 10/15 | -€167,901 | -€191,319 | -€23,418 | -13.9% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€172,901 | -€196,319 | -€23,418 | -13.5% |
| Amounts payable | 17/49 | €1,658,720 | €1,582,878 | -€75,842 | -4.6% |
| Amounts payable after more than one year | 17 | €1,091,344 | €1,089,151 | -€2,193 | -0.2% |
| Other amounts payable | 178/9 | €1,091,344 | €1,089,151 | -€2,193 | -0.2% |
| Amounts payable within one year | 42/48 | €567,376 | €493,727 | -€73,650 | -13.0% |
| Trade debts | 44 | €2,673 | €3,322 | +€649 | +24.3% |
| Suppliers | 440/4 | €2,673 | €3,322 | +€649 | +24.3% |
| Taxes, remuneration and social security | 45 | €225 | - | -€225 | |
| Taxes | 450/3 | €225 | - | -€225 | |
| Other amounts payable | 47/48 | €564,479 | €490,405 | -€74,074 | -13.1% |
| Remuneration, social security and pensions | 62 | €60,301 | - | -€60,301 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €13,867 | €13,867 | = | 0.0% |
| Other operating charges | 640/8 | €3,490 | €6,580 | +€3,090 | +88.6% |
| Gross operating margin | 9900 | €21,321 | -€2,034 | -€23,355 | |
| Operating profit (loss) | 9901 | -€56,336 | -€22,481 | +€33,855 | +60.1% |
| Financial income | 75/76B | - | €61 | +€61 | |
| Recurring financial income | 75 | - | €61 | +€61 | |
| Financial charges | 65/66B | €2,972 | €998 | -€1,974 | -66.4% |
| Recurring financial charges | 65 | €2,972 | €998 | -€1,974 | -66.4% |
| Profit (loss) for the period before taxes | 9903 | -€59,308 | -€23,418 | +€35,889 | +60.5% |
| Profit (loss) for the period | 9904 | -€59,308 | -€23,418 | +€35,889 | +60.5% |
| Profit (loss) for the period to be appropriated | 9905 | -€59,308 | -€23,418 | +€35,889 | +60.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.